Understanding how bone marrow-derived cells (BMDCs) enter the central nervous system (CNS) is critical for the development of therapies for brain-related disorders using hematopoietic stem cells. We investigated the brain damages and blood-brain barrier (BBB) modification following either whole-body irradiation or a myeloablative chemotherapy regimen in mice, and the capacity for these treatments to induce the entry of BMDCs into the CNS. Neither treatment had a lasting effect on brain integrity and both were equally efficient at achieving myeloablation. Injection of bone marrow cells from green fluorescent protein (GFP) transgenic mice was able to completely repopulate the hematopoietic niche in the circulation and in hematopoietic organs (thymus and spleen). However, GFP + cells only entered the brain following whole-body irradiation. We conclude that myeloablation, damages to the brain integrity, or the BBB and peripheral chimerism are not responsible for the entry of BMDCs into the CNS following irradiation.
INTRODUCTION
of high-grade glioma, severe combined immunodeficiency, multiple sclerosis, and other CNS pathologies (6). Despite the high therapeutic potential of BMDCs for Brain-specific macrophages called microglia are responsible for the immune defense of the brain through cerebral pathologies (13) and an inestimable tool to study microglial biology, the mechanisms by which they innate immunity processes (19) . They are the only brain cell type deriving from bone marrow resident hemato-enter the brain are poorly understood. Chimerism is the process by which injected bone poietic stem cells (18, 22) . The recruitment of bone marrow-derived cells (BMDCs) into the brain is highly marrow cells from a donor take over the hematopoietic system of a recipient. The use of the green fluorescent active throughout the embryonic life during which microglia populate the central nervous system (CNS) protein heterozygous (GFP +/− ) transgenic mouse model has eased the study of chimerism by facilitating the (5). It appears to be marginal during the adult life, as self-renewal of microglia could be sufficient to maintain tracking of injected GFP + cells in a GFP − background. Numerous models have been designed to induce chime-the microglial population (1), and more active in pathological conditions such as Alzheimer's disease (8) . It rism in mouse models such as parabiosis, immunosuppression of the recipient mice, and irradiation of the was demonstrated that following whole-body irradiation, bone marrow transplantation was highly efficient to whole body, only the head, or the body with a protected head (24). It appears that only lethal doses of whole-restrict amyloid plaque formation and resolve the cognitive declines of mouse models of Alzheimer's disease body irradiation are able to create an efficient chimerism and to induce migrations of BMDCs to the brain. Con-(23). More recently, a successful gene therapy of xlinked adrenoleukodystrophy (ALD) using lentivirus-cerns have arisen toward the use of irradiation in a clinical setting as the effects of this treatment on brain transduced hematopoietic stem cells in humans was reported (2). A therapeutic potential of bone marrow-integrity and on the permeability of the blood-brain barrier (BBB) are poorly understood. A model of derived microglia was also suggested for the treatment 1150 LAMPRON, LESSARD, AND RIVEST whole-body irradiation with the head protected from transgenic mice were also used in bone marrow transplants and as controls for fluorescence activated cell sor-irradiation showed that BMDCs could not infiltrate the CNS and thus suggested that irradiation-induced dam-ting (FACS) experiments. In both cases, initial strains were obtained from Charles River Laboratories. ages to the brain were responsible for the entry of BMDCs into the CNS. However, such a model leaves Whole-Body Irradiation and Myeloablative Chemotherapy intact many hematopoietic precursors in the vicinity of A week before irradiation or chemotherapy, the mice the brain that could compete with the injected cells for were given water containing a commercially available the niche. Furthermore, the lack of BMDC invasion folmix of antibiotics (SEPTRA, GlaxoSmith Kline, lowing whole-body irradiation with a protected body Mississauga, ON, Canada). Mice were either exposed to demonstrated that peripheral myeloablation is also nec-10 Gy whole-body irradiation using a cobalt-60 source essary for the entry of BMDCs into the brain.
(Theratron-780 model, MDS Nordion, Ottawa, ON, In the present study, we sought to understand the Canada) or received myeloablative chemotherapy. The effects of irradiation on the BBB integrity and to adapt chemotherapy regimen consisted of twice-daily (morna myeloablative chemotherapy regimen commonly used ing and evening) injections of 10 mg/kg of busulfan for in hematopoietic stem cells transplants to determine if 4 days (a total of 80 mg/kg) followed by injections of myeloablation alone is sufficient to allow the entry of 100 mg/kg of cyclophosphamide for 2 days (a total of BMDCs into the brain. We report that whole-body irra-200 mg/kg). The injections were performed in a total diation has no lasting effects on the integrity of the brain volume of 150 µl injected intraperitoneally, alternating or BBB and that although the chemotherapy regimen is sides between each injections. To counter chemotherefficient to create a thorough myeloablation and peripheral apy-induced dehydration, mice received daily 1-ml chimerism, GFP + BMDCs could not enter into the CNS.
injection of saline subcutaneously. Following either These results demonstrate that although irradiation does treatment, mice were transferred to sterile cages and not alter significantly the integrity of the CNS, irradiationgiven previously irradiated food. Antibiotic treatment induced myeloablation and peripheral chimerism alone are continued for a week following treatment. Ten mice not sufficient to induce BMDC entry into the CNS.
were included in each group (control, irradiated, and chemotherapy) and the experiments were performed MATERIALS AND METHODS three separate times.
Animal Treatments
Bone Marrow Transplants All animals were used under the supervision of approved institutional protocols. Unless stated other-Bone marrow cells were obtained by flushing the femurs of mice using PBS containing 5% fetal bovine wise, 3-month-old C57/Bl6 mice were used. GFP +/− The dilutions for antibodies used in fluorescence-activated cell sorting (FACS) are: 1 µl/200 µl of total blood (*), 1.5 µl/200 µl of total blood (**), and 2 µl/200 µl of total blood (***). GFP, green fluorescent protein; IBA-1, ionized calcium binding adaptor molecule 1; Gr-1, granulocyte differentiation antigen 1; Ly6-C, lymphocyte antigen 6 complex, locus C1; PE, phycoerythrin; APC, allophycocyanin; FITC, fluorescein isothiocyanate. Figure 1 . A busulfan-cyclophosphamide chemotherapy regimen is as efficient as whole-body irradiation to induce myeloablation, which was confirmed by fluorescence activated cell sorting (FACS) analysis of the blood of treated and untreated mice. Displayed are the scatter plots of hematopoietic cells isolated by staining for the CD45 antigen (A). Monocytes were also counted by isolating the CD11b + CD115 + cells (B). Represented are the means of the levels observed in three replicates of experiments implicating five mice for each conditions. *p < 0.001 versus wild-type (WT).
serum (FBS, Sigma-Aldrich, St. Louis, MO). The cells 96 h following either irradiation or the end of the chemotherapy regimen. They were sacrificed 3 months later. were filtered on 35-µm nylon mesh (BD Bioscience, San Diego, CA), washed three times in FBS-free PBS (centri-Fluorescence Assisted Cell Sorting (FACS) fugating at 300 × g for 5 min between washes) and counted with a hematocytometer. Cells (2 × 10 7 ) were then Mice were anesthetized using a preparation of ketamine hydrochloride and xylazine. Endocardiac blood injected in the tail vein of recipient mice 6, 24, 48, 72, or samples were taken with heparin-treated syringes and added to the solution and incubated for 30 min at 4°C. The complete list of antibodies used in these experi-kept in ethylenediaminetetraacetic acid (EDTA)-coated vials (Sarstedt, Newton, NC) under constant agitation ments and their dilutions is summarized in Table 1 . Following three more washes in mcPBS, cells were until used, no more than 3 h following sampling. Blood (100 µl) was transferred to 4.9 ml of magnesium-and suspended in 250 µl mcPBS and brought for analysis on a FACS Aria analysis system (BD Biosciences). For calcium-free phosphate-buffered saline solution (mcPBS) containing 5% FBS. Cells were pelleted at 300 × g for every experiment, compensation controls were performed for each antibody on blood collected from 5 min and washed two more times in the same solution and finally suspended in 50 µl of 1% FBS-mcPBS. Non-untreated wild-type mice or GFP + mice for the anti-GFP antibody. The results were analyzed using the FlowJo specific binding sites were blocked by adding 4 µl of CD16/CD32 at 4°C for 30 min. Antibodies were then software (Treestand, Ashland, OR).
Immunohistochemistry serum, 1% bovine serum albumin (BSA), and 0.4% Triton X-100. Using the same buffer solution, the sections were then incubated for 90 min in primary antibody at To collect the brain tissues, mice were deeply anesthetized via an IP injection of a mixture of ketamine room temperature. The sections were then rinsed four times for 5 min in KPBS, followed by a 90-min incubation hydrochloride and xylazine, and then rapidly perfused transcardially with 0.9% saline, followed by 4% para-in fluorochrome-or biotin-conjugated goat secondary antibody. Fluorochromes were fluorescein isothiocyanate formaldehyde/3.8% borax in sodium phosphate buffer (pH 9 at 4°C). Brains were rapidly removed from the (FITC) and tetramethyl rhodamine isothiocyanate (TRITC). For nonfluorescent staining, biotin-conjugated skulls, postfixed overnight, and then placed in a solution containing 10% sucrose diluted in 4% paraformalde-secondary antibodies were detected using the peroxidase-based Vectastain ABC kit (Vector Labs, Burlingame, hyde/3.8% borax buffer (pH 9) overnight at 4°C. The frozen brains were mounted on a microtome (Reichert-CA) following the manufacturer's instructions. The complete list of antibodies used in these experiments Jung, Cambridge Instruments Company, Deerfield, IL), frozen with dry ice, and cut into 25-µm coronal sections and their dilutions is summarized in Table 1 . Sections were then rinsed four times for 5 min in KPBS, mounted from the olfactory bulb to the end of the medulla. The slices were collected in a cold cryoprotectant solution onto SuperFrost slides (Fisher Scientific, Nepean, Ontario, Canada), stained with 4′,6-diamidino-2-phenyl-(0.05 M sodium phosphate buffer, pH 7.3, 30% ethylene glycol, 20% glycerol) and stored at −20°C. Free-floating indole (DAPI) if needed (0.0002% dilution for 10 min; Molecular Probes), and coverslipped with antifade sections were incubated for 30 min in potassium phosphate-buffered saline (KPBS) containing 4% goat medium composed of 96 mM Tris-Hcl, pH 8.0, 24% Figure 3 . Irradiation does not induce a strong, sustained neuroinflammation profile. Expression levels of neuroinflammatory markers of following irradiation were determined by in situ hybridization. A wild-type untreated control served as negative control.
Mice that received a single IP lipopolysaccharide (LPS) injection were included as positive controls. In all images, the white bars represent 50 µm except for the TLR2 images in which the bars represent 100 µm. TLR2, toll-like receptor 2; MCP1, monocyte chemoattractant protein-1; IL-1, interleukin-1; TNF-α, tumor necrosis factor-α glycerol, 9.6% polyvinylalcohol, and 2.5% diazabicyclooctane (Sigma). Confocal laser scanning microscopy was performed with a BX-61 microscope equipped with the Fluoview SV500 imaging software 4.3 (Olympus America Inc, Melville, NY). Confocal images were acquired by sequential scanning using a two-frame Kalman filter and a z-separation of 1 µm.
In Situ Hybridization
In situ hybridization was performed on every 12th section of the brain, starting from the end of the olfactory bulb to the end of the cortex, using 35 S-labeled cRNA probes as described previously (9, 10, 15) . The mRNA probes were generated with the following primers: GGCTCTTCTGGATCTTGGTGGCC (forward) and GGGCCACTCCAGGTAGGTCTTGG (reverse) for A, B) and in the blood-brain barrier (BBB). Immunoglobulin-g (A-E) and brain (C) as determined by FACS analysis of CD45 cells (A) albumin (F-J) staining was used to test the integrity of the and CD11b + CD115 + cells (monocytes, B) or by stereological blood-brain barrier (BBB). Displayed are a positive control (B, analysis of ionized calcium binding adaptor molecule 1 posi-G: a BBB mechanically disrupted by a stereotaxic needle) and tive (IBA-1 + cells in the brain (C). Also included are a negative a representation of the staining we found in untreated wildcontrol (untreated wild-type mice) and a positive control type controls (negative control; A, F), irradiated mice (D, E, (GFP + transgenic mice). In every case, the amount of GFP + I, J), and mice that received chemotherapy (C, H). In all cells in GFP + mice and irradiated mice were significantly difimages, the black bars represent 100 µm except in slides (B) ferent from WT mice (p < 0.0001). and (G) where it represents 50 µm. toll-like receptor 2 (TLR2) and GCCTGTAGCCCACG containing FJB [FJB 0.0004% (Histochem, Jefferson, AR) + acetic acid 0.1% (Sigma-Aldrich) + DAPI 0.0002% TCGTAGC (forward) and AAAGTAGACCTGCCCG GACTC (reverse) for tumor necrosis factor-α (TNF-α).
(Molecular Probes Eugene, OR)] for 20 min. The slides were thereafter rinsed three times in distillated water (1 The probes for interleukin (IL)-1β and monocyte chemoattractant protein-1 (MCP-1) were both kind gifts from min each), dried, dipped in xylene three times (2 min each), and coverslipped with a mounting medium (DPX, Dr. Pennica (7) and Dr. Stiles (20) , respectively. These probes are clones of the full-length cDNAs.
Sigma-Aldrich).
Stereological Analysis Fluorojade Staining
Neuronal death was labeled with the fluoro-jade b Immunostained brain sections were analyzed using a stereological apparatus (n = 4 for each group). Slices (FJB) method. Briefly, every sixth section of the whole rostrocaudal extent of each brain was mounted onto were stained for microglia [anti-IBA-1 (ionized calcium binding adaptor molecule 1)[ (see Table 1 ), GFP, and poly-L-lysine-coated slides, dried under vacuum for 2 h, dehydrated through graded concentrations of alcohol nuclei (DAPI, 2e-4%). A total of 10 animals per group were analyzed. Two sections per animal were selected (50%, 70%, and 100%, 1 min each), and rehydrated through graded concentrations of alcohol (100%, 70%, that contained the hypoglossal nucleus and the loci of migration. Real-time images (1600 × 1200 pixels) were and 50%, 1 min each) and 1 min in distillated water. They were then dipped into and shaken in potassium obtained using a Nikon C80i microscope equipped with both a motorized stage (Ludl) and a Microfire charge permanganate (0.06%) for 10 min, rinsed 1 min in distillated water, and dipped into and shaken in a solution couple device (CCD) color camera (Optronics). Such an apparatus was operated using the Stereo Investigator as mean ± SEM of the number of cells positive for both GFP and IBA-1. software designed by Microbrightfield. The sampling method was previously tested in a pilot study to ensure Statistical Analysis correct estimation in the number of quantified elements.
A two-tailed Student's t-test was performed to deter-First, the Stereo Investigator software was used to mine the statistical significance of the differences delimit counting frames of 670 × 500 µm, and located observed in quantitative experiments. A value of p < at each 2000 µm in the x-axis and at every 1000 µm in 0.05 was used as a cutoff to reach significance. the y-axis of the previously selected cortex and hippocampus regions. Microglia were counted for each frame RESULTS using the pen display, a 40× Plan Apochromat objective Adaptation of a Myeloablative Chemotherapy Regimen (NA 0.95), and a triple-band filter (DAPI/FITC/TRITC, for the Transplantation of Bone Marrow Cells Chroma Technology). IBA-1-immunoreactive cells were counted only when their nuclei (DAPI labeled) were in In order to understand whether myeloablation is sufficient to allow for the entry of BMDCs into the brain, a the dissector area (20 mm) and not in contact with the two forbidden contours of the counting frame. A similar myeloablative chemotherapy regimen was adapted from those used in bone marrow transplants in humans. It method was used for GFP + cells. Results are expressed consisted of 4 days of twice daily injections of 10 mg/ and albumin was observed in the dentate gyrus, the fimbria, and periventricular hypothalamic nucleus of irradi-kg of busulfan followed by 2 days of 100 mg/kg of cyclophosphamide. The advantage of this treatment is ated mice (Fig. 5D , E, I, J). This staining pattern was similar to that observed in untreated controls (Fig. 5A , that it circumvents the need for irradiation and also completely depletes the myeloid cells, including those that F). No sign of immunostaining for IgG or albumin was found in the cortex or any other part of the brain as survive in a protected head irradiation protocol. In our setting, chemotherapy led to a complete depletion of compared to a positive control of a BBB mechanically disrupted with a micro syringe (Fig 5B, G) . These monocytes in the circulation as seen in the scatter plot of CD45 + cells of treated mice (Fig. 1) . We found that results clearly show that whole-body irradiation as a means to permit the entry of BMDCs into the brain has chemotherapy depleted the monocyte population (CD115 + , CD11b + ) by 90.1%, comparable to the 88.6% depletion no effect on the integrity of the BBB and its permeability to components of the circulation. induced by irradiation ( Fig. 1B) .
Limited Effects of Irradiation and Chemotherapy Myeloablation Is Sufficient to Induce Peripheral Chimerism in Bone Marrow Transplantations on Brain Integrity
In order to understand the effects of irradiation on Bone marrow cells from GFP + transgenic mice were injected into wild-type littermates 24 h following either the brain, 3-month-old wild-type C57Bl/6 mice received lethal doses of whole-body irradiation (10 Gy) (Fig. 2) .
irradiation or the end of the chemotherapy regimen. Three months later, GFP + cells were found as abundant Rapid and transient damages to neurons were observed with fluorojade staining of brain sections of these mice in chemotherapy-treated mice as in irradiated mice, representing 75.5% of CD45 + cells and 94.2% of CD115 + / ( Fig. 2A, C, E) . Damage was observed in the olfactory limb, in cells of the caudoputamen bordering the lateral CD11b + cells (Fig. 6A, B ). Most importantly, GFP + cells effectively infiltrated the peripheral organs ( Fig. 6C-H) . ventricles, and in the granular layer of the dentate gyrus. The damages were also found by staining for the apopto-In the spleen, GFP + cells were found both in the red pulp and in lymphatic nodes ( Fig. 6C-E) , implicated respec-sis marker cleaved caspase 3 ( Fig. 2B, D, F) . In all cases, the damage could not be detected 48 h following tively in granulocyte and macrophage maturation and in T-lymphocyte maturation. In the thymus, GFP + cells irradiation and no long-term damage was found 7 days after irradiation. Another concern about irradiation is were restricted to lobules' medulla ( Fig. 6F-H) where T-lymphocytes undergo their final maturation process. that it induces strong, sustained neuroinflammation. However, in situ hybridization for TLR2, MCP-1, IL-1, Thus, chemotherapy was as efficient as irradiation both to induce myeloablation and to allow for a sustained and and TNF-α, all classical markers of neuroinflammation, showed that limited inflammation occurred 6 h after robust chimerism, both in the circulation and in peripheral organs. irradiation but it did not persist (Fig. 3) . Neither cell death nor inflammatory markers could be detected in animals that had received chemotherapy (Figs. 2, 3) .
Myeloablation and Peripheral Chimerism Is Not Sufficient to Induce the Entry of BMDCs Into the Brain Moreover, injecting bone marrow cells from GFP + transgenic mice 6, 24, 48, 72 h, or 7 days after irradiation did not influence the blood chimerism and brain infiltra-Is myeloablation and peripheral chimerism sufficient to allow for the entry of BMDCs into the CNS? We tion of GFP + cells (Fig. 4) , showing that the presence of the damage is not necessary to induce the entry of investigated the presence of GFP + cells in the brain using the hypoglossal nerve axotomy model that induces BMDCs into the brain. a strong migration of microglial cells in the ipsilateral Whole-Body Irradiation and Chemotherapy Does Not side of the hypoglossal nucleus (14) ( Fig. 7A-C) .
Affect the Integrity of the BBB
Microglial cells were revealed by staining for IBA-1. As expected, most IBA-1 + cells that migrated into the Damage to the BBB has been assumed to be responsible for the entry of BMDCs into the brain (17) . We hypoglossal nucleus in mice that had been irradiated were also GFP positive (Fig. 7D, E) , indicating a robust used classic immunostaining for BBB damage by staining for mouse immunoglobulin-g (IgG) and albumin infiltration of BMDCs. GFP + IBA-1 + cells were also found throughout the cortex of irradiated mice (Fig. 7F ). (Fig. 5) . These proteins are only found in the circulation and their presence in the brain is a clear sign of BBB In mice that received chemotherapy, GFP + cells could not be found in the hypoglossal nerve region (Fig. 7G,  disruption (16) . This technique also alleviates the need for complex surgeries that require the installation of ste-H) or anywhere else in the cerebral cortex. GFP + cells were only found in the choroid plexus and the circum-reotaxic dialysis probes and skull screws, themselves disrupting the BBB integrity. Normal staining for IgG ventricular organs (CVOs, Fig.7H, I) . As such, it appears that grafted cells can migrate to regions of the (VEGF) that could induce the entry of the cells. Clearly, further work is needed to understand the effect of irradi-brain not protected by the BBB or the blood-cerebrospinal fluid barrier (BCSFB) but are not able to cross ation on the choroid plexus and the permeability of the BCSFB. through to populate the CNS.
On the other hand, the chemotherapy protocol we DISCUSSION applied was the same that was used to prepare the patients in the gene therapy study of X-linked ALD (2). We report that a lethal dose of whole-body irradiation has limited effects on cell and neuron death in the brain.
Since the results of the therapy are indisputable when comparing the computed tomography (CT) scans of the The limited damages found were all in regions with active neurogenesis (11), which could explain why they treated brains to controls, we can assume that in certain pathological conditions such as ALD, stroke, direct display cell death, as irradiation is known to have more effects on dividing cells (3). These damages could not brain injury, or even Alzheimer's disease, the permeability of the brain to BMDCs is increased and chemother-be detected 24 h after irradiation. The transient nature of the damages in these few regions could also be attrib-apy alone could prove a sufficient pretreatment. Three months after the injection of bone marrow uted to the ability of these cells to regenerate. We could not detect any changes in the integrity of the BBB. Pre-cells, myeloid cells in the circulation and in the brain of irradiated recipient mice were predominantly grafted vious reports on the effects of irradiation on the BBB indicated the contrary. However, most models studying cells. This demonstrates that grafted bone marrow cells are not transient in the CNS and could thus be used for irradiation-induced BBB damages usually use either high doses of irradiation (20-50 Gy) (12) , deliver the the long-term treatment of various pathologies as a onetime treatment option. irradiation directly to the denuded brain or nerve region (12) , and use radiolabeled tracer compounds (4). The
